Thottam GE, Krasnokutsky S, Pillinger MH. Gout and the metabolic syndrome: the tangled web. Curr RheumatolRep. 2017; 19:1–8.
Google Scholar
Dalbeth N, Choi HK, Joosten LA, Khanna PP, Matsuo H, Perez-Ruiz F, StampLK, Gout (Primer), Editors. Nature Review: Disease Primers. 2019; 5 (1).
Liu L, Wang D, Liu M, Yu H, Chen Q, Wu Y, and others Development from hyperuricemia to gout: key mechanisms and natural products for treatment. Acupuncture herbal medicine. 2022; 2(1): 25–32.
Google Scholar
James A, Ke H, Yao T, Wang Y. The role of probiotics in purine metabolism, hyperuricemia, and gout: mechanisms and interventions. Food review int. 2023; 39(1): 261–77.
Google Scholar
Cross M, Ong KL, Culbreth GT, Steinmetz JD, Cousin E, Lenox H, et al., Global, Regional, and National burdens of gout from 1990 to 2020, and forecasts for 2050: a systematic analysis of the global burden of disease research. 2024; 6(8): E507–17.
Google Scholar
Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns, and risk factors. Nat Rev Rheumatol. 2020; 16(7): 380–90.
Kang DH, Chen W. Uric acid and chronic kidney disease: a new understanding of old problems. Nephrology seminar. Richard J, Johnson M, Laura Gabriela Sánchez-Lozada K. Vol. 31. Elsevier; 2011. p. 447–52.
Ichinose K, Matsuguchi H, Takayama T, Nakayama A, Murakami K, Shimamura T, and others Reduced uric acid excretion outside the kidneys is a common cause of hyperuricemia. Nut commune. 2012; 3(1): 764.
Peng S, Luo M, Long D, Liu Z, Tan Q, Huang P, and others Full-length 16S rRNA gene sequencing and machine learning reveal the bacterial composition of inhalable particles from two different breeding stages of pigs. Ecotoxycall environment SAF. 2023; 253:114712.
Guo Z, Zhang J, Wang Z, Ang KY, Huang S, Hou Q, and the other gut microbiota distinguish between gout patients and healthy humans. SciRep. 2016; 6(1): 20602.
A diagnostic model for predicting hyperuricemia based on changes in the gut microbiota in individuals with different serum uric acid levels, such as Liang M, Liu J, Chen W, He Y, Kahaer M, and Li R. Front-end Crinol. 2022; 13:925119.
Google Scholar
Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C. Discovery and description of metagenomic biomarkers. Genomic Biol. 2011; 12:1–18.
Google Scholar
TopçuoğluBD, Lesniak NA, Ruffin IVMT, Wiens J, Schloss PD. A framework for effectively applying machine learning to microbiome-based classification problems. MBIO. 2020; 11 (3). https://doi.org/10.1128/mbio.00434-20.
Aryal S, Alimadadi A, Manandhar I, Joe B, Cheng X. Machine learning strategies for gut microbiota-based diagnostic screening for cardiovascular disease. High blood pressure. 2020; 76(5): 1555–62.
Park Ig, Yoon SJ, Win SM, Oh KK, Hyun JY, Suk KT, Lee U. Park for the diagnosis of alcohol-related and metabolic dysfunction-related fatty liver diseases for gut microbiota-based machine learning signatures. SciRep. 2024; 14(1): 16122.
Shao T, Shao L, Li H, Xie Z, He Z, Wen C. Combined fecal microbiota and metabolome signatures of gout patients. Front Micro Bior. 2017; 8:268.
Cao C, Fan B, Zhu J, Zhu N, Cao JY, Yang DR. Association of gut microbiota and biochemical characteristics in Chinese populations of renal uric acid stone. Front Pharma Call. 2022; 13:888883.
Miyajima Y, Karashima S, Mizoguchi R, Kawakami M, Ogura K, Ogai K, et al. Prediction and causal inference of hyperuricemia using the gut microbiota. SciRep. 2024; 14(1): 9901.
Ul-Haq A, Lee KA, Seo H, Kim S, Jo S, Ko KM, and others Characteristic changes in the gut microbiota in uncontrolled gout. J Microbiol. 2022; 60(12): 1178–90.
Edgar RC. uparse: Very accurate OTU sequence from microbial amplicon reads. NAT method. 2013; 10(10): 996–8.
Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R. Uchime improves the sensitivity and speed of chimeric detection. Bioinformatics. 2011; 27(16): 2194–200.
Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, et al. Silva Ribosomal RNA Gene Database Project: Data Processing and Web-based Tool Improvements. Nucleic acid res. 2012;41 (D1): D590–6.
ImageGP 2 to enhance visualization and reproducible analysis of data in Chen T, Liu YX, Chen T, Yang M, Fan S, Shi M, and others biomedical research. imeta. 2024; 3(5): E239.
Wemheuer F, Taylor JA, Daniel R, Johnston E, Meinicke P, Thomas T, Wemheuer B. Tax4Fun2: Prediction of habitat-specific functional profiles and functional redundancy based on 16S RRNA gene sequences. Environmental microbiome. 2020; 15:1–12.
Google Scholar
Correlation between altered gut microbiota and hyperuricemia in Liu X, LV Q, Ren H, Gao L, Zhao P, Yang X, and others Hyperpure-induced hyperuricemia rats. Peerj. 2020; 8: e8664.
Zhou X, Ji S, Chen L, Liu X, Deng Y, You Y, et al. Isolation of the gut microbiota in uremia promotes renal damage through activation of the NLRP3 inflammasome. Microbiome. 2024; 12(1): 109.
Cao C, Li F, Ding Q, Jin X, Tu W, Zhu H, et al. Clinical features of patients with potassium sodium hydrogen citrate gut microbiome and uric acid stone. Appl Microbiol Biotechnol. 2024; 108(1):51.
Henson MA. Interrogation of the disturbed gut microbiota in patients with gouty arthritis through in silico metabolic modeling. Eng Life Sci. 2021; 21(7): 489–501.
Effect of alcohol on the taxonomic structure of gout arthritis and gut microbiota in Feng Y, Sun H, Zhu R, Tao J, Su R, Sun Y, Wang D. C57BL/6 mice. Front Micro Bior. 2023; 14:1257701.
Chu Y, Sun S, Huang Y, Gao Q, Xie X, Wang P, et al metagenomic analysis revealed the potential role of the gut microbiota in gout. NPJ Biofilm Microbiome. 2021; 7(1):66.
Zhao F, Zhao Z, Man D, Sun Z, Tie N, Li H, Zhang H. Changes in the structure and function of the gut microbiota in gout patients. Food Bioscience. 2023; 54:102912.
Google Scholar
Chen Y, Zhu L, Hu W, Wang Y, Wen X, Yang J. Simiao Wan regulates gut microbiota and bile acid metabolism during the improvement of type 2 diabetes in mice. Plant medicine. 2022; 104:154264.
Kinematic studies of hypoxanthine oxidation by Escribano J, Garcia-Canovas F, Garcia-Carmona F. Milkxanthine oxidase. Biochem J. 1988; 254(3): 829–33.
Wang Y, Deng M, Deng B, Ye L, Fei X, Huang Z. Studies on the diagnosis of gout with xanthine and hypoxanthine. J Clin Lab Anal. 2019; 33(5): E22868.
Hannou SA, Haslam DE, McKeown NM, Herman MA. Fructose metabolism and metabolic diseases. J Clin Investicagh. 2018; 128(2): 545–55.
Yin H, Liu N, Chen J. The role of the intestine in the development of hyperuricemia. Front imnor. 2022; 13:845684.
Liu Y, Yu P, Sun X, Di D. Metabolite target analysis of human urine in combination with pattern recognition techniques for the study of symptomatic gout. Mol Biosyst. 2012; 8(11): 2956–63.
Using Chen W, Liu Y, Wei M, Shi L, Wu Y, Liu Z, et al. UPLC-ESI-Q-TOF/MS metabolomics approach, studies on the effects of acute gout leaves in ginkgo biloba L. with acute pain model rats. RSC Adv. 2017;7(68):42964–72.
Chen Y, Tang Z, Huang Z, Zhou W, Li Z, Li X, Sun F. J Public Health. 2017; 25:521–9.
Google Scholar
Characteristics and metabolic markers of specific gut microbiota in obese postmenopausal women, including Brahe LK, Le Chatelier E, Prifti E, Pons N, Kennedy S, and Hansen T. Nutritional diabetes. 2015; 5(6): E159 – e.
Singh AK, Durairajan SSK, Iyaswamy A, Williams LL. The role of segregation of the gut microbiota in hyperuricemia and gout: insights and treatment strategies. World J Gastroenterol. 2024; 30 (40): 4404.
Sheng S, Chen J, Zhang Y, Qin Q, Li W, Yan S, et al. Structural and functional alterations of the gut microbiota in men with hyperuricemia and high levels of liver enzymes. Front Med. 2021; 8:779994.
Google Scholar
Lin S, Zhang T, Zhu L, Pang K, Lu S, Liao X, and other effects of characteristic partitioning and uric acid-lowering treatment in gout, Febuxostat on the gut microbiota. J Genet Genomics. 2021; 48(9): 781–91.
Kino S, Hsu YT, Shiba K, Chien YS, Mita C, Kawachi I, Daoud A. Health of the SSM population. 2021; 15:100836.
Possibility of diagnosing salivary microbiota in persistent pulmonary nodules, including Zeng X, Ma Q, Huang CX, Xiao JJ, Fu X, Ren YF: Identification of biomarkers and functional pathways using 16S RRNA sequencing and machine learning. J Translational Med. 2024; 22(1): 1079.
Tani T, Okamoto K, Fujiwarara M, Katayama A, Tsuruoka S. Metabolomics analysis elucidates the unique effects of xanthine oxidoreductase inhibitors on purine/pyrimidine metabolism in a rat model of renal ischemia supplementation damage. Mol Med. 2019; 25:1–13.
Taxonomic variation in the gut microbiota in gout patients, including Méndez-SalazarEO, Vázquez-Mellado J, Casimiro-Soriguer CS, Dopazo J, chubuk C, Zamudio-Cuevas Y, with or without Tophi, can have functional influence on uric acid metabolism. Mol Med. 2021; 27:1–13.
Google Scholar
